Heparininduzierte thrombozytopenie vom typ II bei einem patienten mit biventrikularem unterstutzungssystem

R. Sodian; Matthias Loebe; J. Hofmeister; A. Koster; H. Riess; R. Hetzer

doi:10.1007/s003980050030

Heparininduzierte thrombozytopenie vom typ II bei einem patienten mit biventrikularem unterstutzungssystem

Translated title of the contribution: Heparin-induced thrombocytopenia type II in a patient with biventricular assist device

R. Sodian, Matthias Loebe, J. Hofmeister, A. Koster, H. Riess, R. Hetzer

Academic Institute

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Heparin-induced Thrombocytopenia (HIT) is a life threatening complication of anticoagulatory therapy with Heparin. We report on a 35 year old patient suffering from cardiomyopathy for whom a biventricular assist device (Berlin Heart) became necessary. This patient developed a HIT Type II postoperatively and was treated with Orgaran, an effective Heparin substitute in a patient with HIT Type II. After 213 days with the biventricular assist device our patient successfully underwent orthotopic heart transplantation with Orgaran. This medication can also be administered to assist device patients and can also be used as an anticoagulant during cardiopulmonary bypass.

Translated title of the contribution	Heparin-induced thrombocytopenia type II in a patient with biventricular assist device
Original language	German
Pages (from-to)	140-143
Number of pages	4
Journal	Zeitschrift fur Herz-, Thorax- und Gefasschirurgie
Volume	12
Issue number	3
DOIs	https://doi.org/10.1007/s003980050030
State	Published - Jan 1 1998

Keywords

Assist device
Heart transplantation
Heparin-induced thrombozytopenia
Orgaran

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1007/s003980050030

Cite this

@article{701ff0f3532641dca9824719b018d240,

title = "Heparininduzierte thrombozytopenie vom typ II bei einem patienten mit biventrikularem unterstutzungssystem",

abstract = "Heparin-induced Thrombocytopenia (HIT) is a life threatening complication of anticoagulatory therapy with Heparin. We report on a 35 year old patient suffering from cardiomyopathy for whom a biventricular assist device (Berlin Heart) became necessary. This patient developed a HIT Type II postoperatively and was treated with Orgaran, an effective Heparin substitute in a patient with HIT Type II. After 213 days with the biventricular assist device our patient successfully underwent orthotopic heart transplantation with Orgaran. This medication can also be administered to assist device patients and can also be used as an anticoagulant during cardiopulmonary bypass.",

keywords = "Assist device, Heart transplantation, Heparin-induced thrombozytopenia, Orgaran",

author = "R. Sodian and Matthias Loebe and J. Hofmeister and A. Koster and H. Riess and R. Hetzer",

year = "1998",

month = jan,

day = "1",

doi = "10.1007/s003980050030",

language = "German",

volume = "12",

pages = "140--143",

journal = "Zeitschrift fur Herz-, Thorax- und Gefasschirurgie",

issn = "0930-9225",

publisher = "D. Steinkopff-Verlag",

number = "3",

}

TY - JOUR

T1 - Heparininduzierte thrombozytopenie vom typ II bei einem patienten mit biventrikularem unterstutzungssystem

AU - Sodian, R.

AU - Loebe, Matthias

AU - Hofmeister, J.

AU - Koster, A.

AU - Riess, H.

AU - Hetzer, R.

PY - 1998/1/1

Y1 - 1998/1/1

N2 - Heparin-induced Thrombocytopenia (HIT) is a life threatening complication of anticoagulatory therapy with Heparin. We report on a 35 year old patient suffering from cardiomyopathy for whom a biventricular assist device (Berlin Heart) became necessary. This patient developed a HIT Type II postoperatively and was treated with Orgaran, an effective Heparin substitute in a patient with HIT Type II. After 213 days with the biventricular assist device our patient successfully underwent orthotopic heart transplantation with Orgaran. This medication can also be administered to assist device patients and can also be used as an anticoagulant during cardiopulmonary bypass.

AB - Heparin-induced Thrombocytopenia (HIT) is a life threatening complication of anticoagulatory therapy with Heparin. We report on a 35 year old patient suffering from cardiomyopathy for whom a biventricular assist device (Berlin Heart) became necessary. This patient developed a HIT Type II postoperatively and was treated with Orgaran, an effective Heparin substitute in a patient with HIT Type II. After 213 days with the biventricular assist device our patient successfully underwent orthotopic heart transplantation with Orgaran. This medication can also be administered to assist device patients and can also be used as an anticoagulant during cardiopulmonary bypass.

KW - Assist device

KW - Heart transplantation

KW - Heparin-induced thrombozytopenia

KW - Orgaran

UR - http://www.scopus.com/inward/record.url?scp=0031815795&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031815795&partnerID=8YFLogxK

U2 - 10.1007/s003980050030

DO - 10.1007/s003980050030

M3 - Article

AN - SCOPUS:0031815795

SN - 0930-9225

VL - 12

SP - 140

EP - 143

JO - Zeitschrift fur Herz-, Thorax- und Gefasschirurgie

JF - Zeitschrift fur Herz-, Thorax- und Gefasschirurgie

IS - 3

ER -

Heparininduzierte thrombozytopenie vom typ II bei einem patienten mit biventrikularem unterstutzungssystem

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this